Researchers at the University of Southampton have developed a promising new way to bolster the body’s immune system response to cancer. They used specially engineered multi-pronged antibodies to better activate immune response to cancer-killing T cells. The antibodies work by…
Eli Lilly is deepening its investment in inflammatory diseases, spending $1.2 billion to buy Ventyx Biosciences for an experimental drug that has the potential to treat an array of immunological conditions. The Indiana-based manufacturer of obesity drug Zepbound announced Wednesday…
Kidney xenotransplantation and sample collection An EGEN-2784 gene-edited pig kidney was transplanted into a 62-year-old male patient with end-stage kidney disease, recently described in ref. 5. A Yucatan miniature pig was genetically engineered with 69 genomic modifications. These included the…
Vaccination rates for kindergartners in three Western Massachusetts counties have dropped below what is necessary to secure herd immunity against measles, according to data released last week by the Washington Post. About 93.8% of kindergarteners in Hampden County have received…
In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a bold new front. With $1 million in funding from Breakthrough T1D, the leading global T1D research and advocacy organization,…
In a remarkable leap forward for immunology and neurobiology, new research has uncovered a groundbreaking neuro-epithelial circuit that orchestrates intestinal immunity through the sensory convergence of pain-sensing neurons and specialized epithelial cells. This discovery unveils an intricate dialogue between TRPV1^+…
